Christophe M Legendre

18PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Forensic psychologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 01, 2025
Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.

Agathe Truchot, Marc Raynaud, Ilkka Helanterä

|Oct 16, 2024
Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.

Agathe Truchot, Marc Raynaud, Ilkka Helanterä

|Jul 18, 2024
A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody-Mediated Rejection.

Fabian Halleck, Georg A Böhmig, Lionel Couzi

|Sep 15, 2023
Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition.

Charles Bayard, Eleonora Segna, Maxime Taverne

|Nov 08, 2021
Long-term survival benefit from dual kidney transplantation using kidneys from donors with very extended criteria-a French cohort between 2002 and 2014.

Emilie Savoye, Christophe Legendre, Yann Neuzillet

|Jan 29, 2021
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study.

Camille Lanaret, Dany Anglicheau, Vincent Audard

Pageof 3